Cutaneous photoprotection

Archives of Dermatology

Volumn 139, Issue 4, 2003, Pages 527-530

  Hawk, John L M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; PHOTODERMATOSIS; PRIORITY JOURNAL; PROTECTION; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

CLOTHING; HUMANS; KERATOSIS; PHOTOSENSITIVITY DISORDERS; RADIATION PROTECTION; SKIN; SUNBURN; SUNLIGHT; SUNSCREENING AGENTS;

EID: 0037386873     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.4.527     Document Type: Editorial

References (49)

1. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003;139:451-455.
2. Green A, Williams G, Neale R, et al. Daily sunscreen application and beta carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354:723-729.
3. Norris PG, Hawk JLM. The idiopathic photodermatoses: polymorphic light eruption, actinic prurigo and hydroa vacciniforme. In: Hawk JLM, ed. Photodermatology. London, England: Arnold; 1999:178-190.
4. Hawk JLM, ed. Photodermatology. London, England: Arnold; 1999:1-328.
5. Grant RH, Heisler GM, Gao W. Estimation of pedestrian level UV exposure under trees. Photochem Photobiol. 2002;75:369-376.
6. Magnus IA. Sunlight. In: Dermatological Photobiology. London, England: Blackwell Scientific Publications; 1976:35-40.
7. Diffey BL. What is light? Photodermatol Photoimmunol Photomed. 2002;18: 68-74.
8. Gray J, Hawk JLM. The Benefits of Lifetime Photoprotection. London, England: Royal Society of Medicine Press Ltd; 1998:1-34.
9. du Peloux Menagé H, Hawk JLM. The idiopathic photodermatoses: chronic actinic dermatitis. In: Hawk JML, ed. Photodermatology. London, England: Arnold; 1999:190-202.
10. Hölzle E. Solar urticaria. In: Hawk JML, ed. Photodermatology. London, England: Arnold; 1999:204-212.
11. Gambichler T, Altmeyer P, Hoffmann K. Role of clothes in sun protection. Recent Results Cancer Res. 2002;160:15-25.
12. Davis S, Capjack L, Kerr N, et al. Clothing as protection from ultraviolet radiation: which fabric is most effective? Int J Dermatol. 1997;36:374-379.
13. Gambichler T, Rotterdam S, Altmeyer P, Hoffmann K. Protection against ultraviolet radiation by commercial summer clothing: need for standardised testing and labelling. BMC Dermatol. 2001;1:6.
14. Menter JM, Hollins TD, Sayre RM, et al. Protection against UV photocarcinogenesis by fabric materials. J Am Acad Dermatol. 1994;31:711-716.
15. Jevtic AP. The sun protective effect of clothing, including beachwear. Australas J Dermatol. 1990;31:5-7.
16. Stanford DG, Georgouras KE, Pailthorpe MT. Sun protection by a summer-weight garment: the effect of washing and wearing. Med J Aust. 1995;162:422-425.
17. Gies PH, Roy CR, Toomey S, et al. Protection against solar ultraviolet radiation. Mutat Res. 1998;422:15-22.
18. Laperre J, Gambichler T, Driscoll C, et al. Determination of the ultraviolet protection factor of textile materials: measurement precision. Photodermatol Photoimmunol Photomed. 2001;17:223-229.
19. Santmyire BR, Feldman SR, Fleischer AB Jr. Lifestyle high-risk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States: results of the 1998 National Health Interview Survey. Cancer. 2001;92:1315-1324.
20. Boyett T, Davy L, Weathers L, Campbell R, Van Durme D, Roetzheim RG. Sun protection of children at the beach. J Am Board Fam Pract. 2002;15:112-117.
21. Shaath NA. On the theory of ultraviolet absorption by sunscreen chemicals. J Soc Cosmet Chem. 1987;82:193-198.
22. Bissett DL, Hannon DP, Orr TV. Wavelength dependence of histological, physical and visible changes in chronically irradiated hairless mouse skin. Photochem Photobiol. 1990;50:763-769.
23. Kligman LH, Akin FJ, Kligman AM. Sunscreens prevent ultraviolet carcinogenesis. J Am Acad Dermatol. 1980;3:30-35.
24. Kaidbey KH. The photoprotective potential of the new superpotent sunscreens. J Am Acad Dermatol. 1990;22:449-452.
25. Young AR, Sheehan JM, Chadwick CA, Potten CS. Protection by UVA and UVB sunscreens against in situ dipyrimidine photolesions in human epidermis is comparable to protection against sunburn. J Invest Dermatol. 2000;115:37-41.
26. Walker SL, Young AR. Sunscreens offer the same UVB protection factors for inflammation and immunosuppression in the mouse. J Invest Dermatol. 1997; 108:133-138.
27. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147-1151.
28. Naylor MF, Boyd A, Smith DW, et al. High sun protection factor sunscreens in the suppression of actinic neoplasia Arch Dermatol. 1995;131:170-175.
29. Autier P, Doré J-F, Schifflers E, et al. Melanoma and use of sunscreens: an EORTC case-control study in Germany. Int J Cancer. 1995;61:749-755.
30. Wolf P, Quehenberger F, Mülleger R, Stranz B, Kerl H. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study. Melanoma Res. 1998;8:370-378.
31. Westerdahl J, Olsson H, Masbäck A, Ingvar C, Jonsson N. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res. 1995;5:59-65.
32. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women, I: exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol. 1995;141:923-933.
33. Rodenas JM, Delgado-Rodriguez M, Herranz M, Tercedor J, Serrano S. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control. 1996;7: 275-283.
34. Robinson JK, Rademaker AW. Sun protection by families at the beach. Arch Pediatr Adolesc Med. 1998;152:466-470.
35. Diffey BL. When should sunscreen be reapplied? J Am Acad Dermatol. 2001; 45:882-885.
36. Bech-Thornsen N, Wulf HC. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed. 1992;9:242-244.
37. Wright MW, Wright ST, Wagner RF. Mechanisms of sunscreen failure. JAmAcad Dermatol. 2001;44:781-784.
38. Sayre RM, Dowdy JC. Photostability testing of avobenzone. Cosmet Toiletries. 1999;114:85-91.
39. Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, Walker SL. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med. 2000;191:561-566.
40. Foley P, Nixon R, Marks R, Frowen K, Thompson S. The frequency of reactions to sunscreens: results of a longitudinal population-based study on the regular use of sunscreens in Australia. Br J Dermatol. 1993;128:512-518.
41. Waiters KA, Brain KR, Howes D, et al. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro. Food Chem Toxicol. 1997;35:1219-1225.
42. Farrerons J, Barnadas M, Rodriguez J, et al. Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers. Br J Dermatol. 1998;139:422-427.
43. Diffey BL. Is daily use of sunscreens of benefit in the U.K.? Br J Dermatol. 2002; 146:659-662.
44. Hawk JLM, Parrish JA. Responses of normal skin to ultraviolet radiation. In: Regan JD, Parrish JA, eds. The Science of Photomedicine. New York, NY: Plenum Press; 1982:212-260.
45. Hawk J. Skin photoaging and the health benefits of cutaneous photoprotection. In: Coohill TP, Valenzeno DP, eds. Photobiology for the 21st Century. Overland Park, Kan: Valdenmar Publishing Co; 2001:31-40.
46. Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol. 2002;146:94-100.
47. Patel DC, Bellaney GJ, Seed PT, McGregor JM, Hawk JLM. Efficacy of shortcourse oral prednisolone in polymorphic light eruption: a randomized controlled trial. Br J Dermatol. 2000;143:828-831.
48. Suga Y, Hashimoto Y, Matsuba S, et al. Topical tacrolimus for chronic actinic dermatitis. J Am Acad Dermatol. 2002;46:321-323.
49. Yarosh D, Klein J, O'Connor A, et al, for the Xeroderma Pigmentosum Study Group. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Lancet. 2001;357:926-929.